La Marca A

No ORCID on file · 7 papers in corpus · active 2017-2026

Study types

  • other 4
  • review 2

Condition tags

  • adenomyosis 4
  • endometriosis 3
  • chronic_pelvic_pain 2
  • dyspareunia 1
  • infertility 1
  • dysmenorrhea 1
  • die_deep_infiltrating 1
other 2026
Gynecologic and obstetric investigation ·doi:10.1159/000550102

OBJECTIVES: The objective of this study was to evaluate whether ultrasound-based #Enzian classification predicts pain profiles and response to hormonal therapy in patients with endometriosis. Endometriosis is a chronic inflammatory disease …

other 2026
Minerva obstetrics and gynecology ·doi:10.23736/S2724-606X.25.05857-9

Adenomyosis is the presence of endometrial glands and stroma within the myometrial wall of the uterus. This condition is related to a diffusely enlarged uterus with reactive hyperplasia and fibrosis of the surrounding myometrial smooth musc…

other 2025
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2025.2514746

BACKGROUND: This is the first report aimed to evaluate the clinical impact and safety of sequential treatment with relugolix combination therapy (relugolix CT) in women with symptomatic uterine fibroids that were inadequately managed with 5…

other 2025
Minerva obstetrics and gynecology ·doi:10.23736/S2724-606X.24.05518-0

BACKGROUND: Patients with endometriosis are thought to have been impacted by the COVID-19 pandemic and estimates suggest that 6.2% of them were infected with SARS-CoV-2. METHODS: This is a retrospective cohort study enrolling 284 women at …

review 2024
Expert opinion on drug metabolism & toxicology ·doi:10.1080/17425255.2024.2441981

INTRODUCTION: In ovarian steroid-dependent diseases such as uterine fibroids, endometriosis and adenomyosis, oral GnRH antagonists have emerged as new therapeutic alternatives. These oral GnRH antagonists offer key advantages, including ora…

review 2023
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2022.102301

A high ovarian response to conventional ovarian stimulation (OS) is characterized by an increased number of follicles and/or oocytes compared with a normal response (10-15 oocytes retrieved). According to current definitions, a high respons…

2017
Human reproduction open ·doi:10.1093/hropen/hox018

Study questionHow much variation in oocyte yield after controlled ovarian stimulation (COS) can be accounted for by known patient and treatment characteristics?Summary answerThere is substantial variation in the COS responses of similar wom…